Opiant Pharmaceuticals revenue

Opiant Pharmaceuticals revenue decreased from $18.4 million in 2017 to $14 million in 2018, a 24.2% decrease.

Annual Revenue ($)

Opiant Pharmaceuticals revenue was $13.98 m in FY, 2018 which is a 24.2% year over year decrease from the previous period.

Quarterly Revenue ($)

FY, 2017FY, 2018
Revenue$18.45 m$13.98 m
Growth(24.2%)
Q2, 2017Q3, 2017Q1, 2018Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019
Revenue$13.54 m$18.12 k$22 k$1.70 m$3.15 m$4.37 m$5.44 m$6.78 m